Balyasny Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-372,793
| Closed | -$6.71M | – | 1471 |
|
|
2020
Q2 | $6.71M | Buy |
+372,793
| New | +$6.71M | 0.06% | 370 |
|
|
2020
Q1 | – | Sell |
-278,043
| Closed | -$6.64M | – | 1519 |
|
|
2019
Q4 | $6.64M | Buy |
278,043
+66,154
| +31% | +$1.58M | 0.04% | 470 |
|
|
2019
Q3 | $5.68M | Buy |
211,889
+78,508
| +59% | +$2.11M | 0.04% | 464 |
|
|
2019
Q2 | $3.62M | Buy |
+133,381
| New | +$3.62M | 0.02% | 595 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1634 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1699 |
|
|
2018
Q2 | – | Sell |
-15,449
| Closed | -$505K | – | 2064 |
|
|
2018
Q1 | $505K | Buy |
+15,449
| New | +$505K | ﹤0.01% | 1249 |
|
|
2017
Q4 | – | Sell |
-5,300
| Closed | -$286K | – | 2108 |
|
|
2017
Q3 | $286K | Sell |
5,300
-319,900
| -98% | -$17.3M | ﹤0.01% | 1349 |
|
|
2017
Q2 | $18.3M | Sell |
325,200
-310,445
| -49% | -$17.4M | 0.08% | 300 |
|
|
2017
Q1 | $24.9M | Buy |
+635,645
| New | +$24.9M | 0.12% | 215 |
|
|
2016
Q3 | – | Sell |
-388,026
| Closed | -$9.16M | – | 1203 |
|
|
2016
Q2 | $9.16M | Buy |
388,026
+121,539
| +46% | +$2.87M | 0.06% | 314 |
|
|
2016
Q1 | $5.44M | Sell |
266,487
-232,651
| -47% | -$4.75M | 0.03% | 403 |
|
|
2015
Q4 | $25.7M | Buy |
+499,138
| New | +$25.7M | 0.18% | 156 |
|